ZFIN ChEBI: polyether

Relationships

is a type of: ether

ether Show first 5 Terms
has subtype: (R)-laudanosine (S)-glaucine 1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline 1-amino-15-oxo-4,7,10-trioxa-14-azaoctadecan-18-oic acid 1-ethoxy-2-(2-ethoxyethoxy)ethane ... Show All 63 Terms

(R)-laudanosine (S)-glaucine 1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline 1-amino-15-oxo-4,7,10-trioxa-14-azaoctadecan-18-oic acid 1-ethoxy-2-(2-ethoxyethoxy)ethane 2,2-dimethyl-3,6,9,12,15-pentaoxa-2-silahexadecane 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl]amino}-2-(propan-2-yl)pentanenitrile 3,6,9,12,15,18-hexaoxaicosane 3,6,9,12,15-pentaoxaheptadecane 7-amino-1-(5-nitro-2-furyl)-1,8-dioxo-11,14,17,20,23-pentaoxa-2-azahexacosan-26-amide aconine benzoylaconine benzoylhypaconine benzoylmesaconine bianfugenine chasmanine crassicauline A crown ether deoxyaconitine diether diglyme eribulin florbetaben ((18)F) foresaconitine foresticine GCB hexamidine hokbusine A hydroxypolyether hypaconine Jeffamine ED-2001 Jeffamine M-600 linkable staurosporine analogue mesaconine N(2)-[3-(2-{2-[({1-[(1-{3-[2-(2-{[4-(indol-3-yl)butanoyl]amino}ethoxy)ethoxy]propanoyl}piperidin-4-yl)carbonyl]piperidin-4-yl}carbonyl)amino]ethoxy}ethoxy)propanoyl]-N(6)-(5-nitro-2-furoyl)lysinamide N(2)-{3-[2-(2-{[(1-{3-[2-(2-{[4-(indol-3-yl)butanoyl]amino}ethoxy)ethoxy]propanoyl}piperidin-4-yl)carbonyl]amino}ethoxy)ethoxy]propanoyl}-N(6)-(5-nitro-2-furoyl)lysinamide N(2)-{3-[2-(2-{[(1-{N-[(1-{3-[2-(2-{[4-(indol-3-yl)butanoyl]amino}ethoxy)ethoxy]propanoyl}piperidin-4-yl)carbonyl]glycyl}piperidin-4-yl)carbonyl]amino}ethoxy)ethoxy]propanoyl}-N(6)-(5-nitro-2-furoyl)lysinamide N-(18-amino-18-oxo-3,6,9,12,15-pentaoxaoctadec-1-yl)-N(2)-{3-[2-(2-{[(1-{[1-({1-[(1-{3-[2-(2-{[4-(indol-3-yl)butanoyl]amino}ethoxy)ethoxy]propanoyl}piperidin-4-yl)carbonyl]piperidin-4-yl}carbonyl)piperidin-4-yl]carbonyl}piperidin-4-yl)carbonyl]amino}ethoxy)ethoxy]propanoyl}-N(6)-(5-nitro-2-furoyl)lysinamide N-deethylaconine N-{1-amino-6-[(5-nitro-2-furoyl)amino]-1-oxohexan-2-yl}-23-(indol-3-yl)-20-oxo-4,7,10,13,16-pentaoxa-19-azatricosan-1-amide N-{1-amino-6-[(5-nitro-2-furoyl)amino]-1-oxohexan-2-yl}-26-(indol-3-yl)-23-oxo-4,7,10,13,16,19-hexaoxa-22-azahexacosan-1-amide N-{1-amino-6-[(5-nitro-2-furoyl)amino]-1-oxohexan-2-yl}-32-(indol-3-yl)-29-oxo-4,7,10,13,16,19,22,25-octaoxa-28-azadotriacontan-1-amide N-{1-amino-6-[(5-nitro-2-furoyl)amino]-1-oxohexan-2-yl}-80-(indol-3-yl)-77-oxo-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,55,58,61,64,67,70,73-tetracosaoxa-76-azaoctacontan-1-amide naloxegol neojiangyouaconitine neoline O-(2-aminopropyl)-O'-(2-methyoxyethyl)octa(propylene glycol) oxonitine pectenotoxin-11 pentaglyme poly(ethylene glycol) derivative propamidine sinomendine Src Inhibitor-1 Src Inhibitor-5 syringaresinol tetraglyme thalicpureine triglyme yunaconitine zilucoplan ZM447439 Show first 5 Terms

Phenotype

Phenotype resulting from polyether

Phenotype where environments contain polyether

Phenotype modified by environments containing polyether

Human Disease Model